Bingxiang Zhang

493 total citations
8 papers, 420 citations indexed

About

Bingxiang Zhang is a scholar working on Biomedical Engineering, Materials Chemistry and Biomaterials. According to data from OpenAlex, Bingxiang Zhang has authored 8 papers receiving a total of 420 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Biomedical Engineering, 5 papers in Materials Chemistry and 4 papers in Biomaterials. Recurrent topics in Bingxiang Zhang's work include Nanoplatforms for cancer theranostics (6 papers), Advanced Nanomaterials in Catalysis (5 papers) and Nanoparticle-Based Drug Delivery (4 papers). Bingxiang Zhang is often cited by papers focused on Nanoplatforms for cancer theranostics (6 papers), Advanced Nanomaterials in Catalysis (5 papers) and Nanoparticle-Based Drug Delivery (4 papers). Bingxiang Zhang collaborates with scholars based in China. Bingxiang Zhang's co-authors include Yongwei Hao, Hongling Zhang, Yun Zhang, Lei Wang, Zhenzhong Zhang, Jinjin Shi, Cuixia Zheng, Dong Li, Yalin Zhao and Quanli Gao and has published in prestigious journals such as Journal of Controlled Release, Nanotechnology and Colloids and Surfaces B Biointerfaces.

In The Last Decade

Bingxiang Zhang

8 papers receiving 417 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bingxiang Zhang China 8 276 151 138 102 67 8 420
Chunshu Pan China 13 315 1.1× 148 1.0× 215 1.6× 87 0.9× 34 0.5× 24 527
Guifeng Fu China 8 280 1.0× 107 0.7× 124 0.9× 107 1.0× 32 0.5× 11 408
Vertika Pathak Germany 8 429 1.6× 310 2.1× 121 0.9× 158 1.5× 40 0.6× 8 628
Wenchang Guo China 6 289 1.0× 141 0.9× 157 1.1× 91 0.9× 28 0.4× 16 459
Mingxi Zhang China 12 380 1.4× 86 0.6× 268 1.9× 119 1.2× 29 0.4× 32 526
Xinghang Dai China 7 293 1.1× 224 1.5× 162 1.2× 140 1.4× 24 0.4× 9 481
Yuancheng Li United States 7 246 0.9× 223 1.5× 96 0.7× 154 1.5× 41 0.6× 13 459
Elliott Hayden United States 4 302 1.1× 301 2.0× 95 0.7× 108 1.1× 36 0.5× 6 498
Haizhen Jin China 9 268 1.0× 156 1.0× 130 0.9× 140 1.4× 30 0.4× 20 486

Countries citing papers authored by Bingxiang Zhang

Since Specialization
Citations

This map shows the geographic impact of Bingxiang Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bingxiang Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bingxiang Zhang more than expected).

Fields of papers citing papers by Bingxiang Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bingxiang Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bingxiang Zhang. The network helps show where Bingxiang Zhang may publish in the future.

Co-authorship network of co-authors of Bingxiang Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Bingxiang Zhang. A scholar is included among the top collaborators of Bingxiang Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bingxiang Zhang. Bingxiang Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Gao, Quanli, Linlin Li, Lu Han, et al.. (2021). The Application of Nanobody in CAR-T Therapy. Biomolecules. 11(2). 238–238. 83 indexed citations
2.
Zhang, Yun, Jinjin Shi, Zhenzhong Zhang, et al.. (2016). Manganese dioxide nanosheets-based redox/pH-responsive drug delivery system for cancer theranostic application. International Journal of Nanomedicine. 11. 1759–1759. 53 indexed citations
3.
Hao, Yongwei, Bingxiang Zhang, Cuixia Zheng, et al.. (2016). Multifunctional nanoplatform for enhanced photodynamic cancer therapy and magnetic resonance imaging. Colloids and Surfaces B Biointerfaces. 151. 384–393. 32 indexed citations
4.
Hao, Yongwei, Bingxiang Zhang, Cuixia Zheng, et al.. (2015). The tumor-targeting core–shell structured DTX-loaded PLGA@Au nanoparticles for chemo-photothermal therapy and X-ray imaging. Journal of Controlled Release. 220(Pt A). 545–555. 100 indexed citations
5.
Hao, Yongwei, Lei Wang, Bingxiang Zhang, et al.. (2015). Multifunctional nanosheets based on folic acid modified manganese oxide for tumor-targeting theranostic application. Nanotechnology. 27(2). 25101–25101. 49 indexed citations
6.
Wang, Lei, Yongwei Hao, Yalin Zhao, et al.. (2015). Gold nanostars mediated combined photothermal and photodynamic therapy and X-ray imaging for cancer theranostic applications. Journal of Biomaterials Applications. 30(5). 547–557. 31 indexed citations
7.
Hao, Yongwei, Lei Wang, Yalin Zhao, et al.. (2015). Targeted Imaging and Chemo‐Phototherapy of Brain Cancer by a Multifunctional Drug Delivery System. Macromolecular Bioscience. 15(11). 1571–1585. 55 indexed citations
8.
Ren, Guoyu, et al.. (2014). Urbanization effect on long-term trends of extreme temperature indices at Shijiazhuang station, North China. Theoretical and Applied Climatology. 119(3-4). 407–418. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026